Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

The Rheumatologist: December 2012

What Rheumatologists Need to Know about Diagnosing and Managing Interstitial Lung Disease (ILD)

Aryeh Fischer, MD, and Jeff Swigris, DO, MS  |  December 1, 2012

Patients with systemic sclerosis (SSc), poly-/dermatomyositis (PM/DM), or rheumatoid arthritis (RA) appear to carry the greatest risk for developing connective tissue disease-associated interstitial lung disease (CTD-ILD)
 

Online Medical Information Adds New Dimension to Patients’ Discussions with Doctors

Vanessa Caceres  |  December 1, 2012

Patients and rheumatologists find pros and cons in Web-based research

Strategic Thinking to Advance Rheumatology in the New Year

Audrey B. Uknis, MD  |  December 1, 2012

One of the first efforts this coming year will be the development of the American College of Rheumatology’s (ACR’s) 2013-2016 strategic plan

No Easy Solution for Lack of Transparency in the Practice of Medicine

Simon M. Helfgott, MD  |  December 1, 2012

Several well-publicized episodes highlight the apparent lack of disclosure of conflicts of interest in medicine, but will disclosure laws fix the problem or add to the confusion?

Foundation Research Explores Relationship Between RA and Cardiovascular Disease

Staff  |  December 1, 2012

A grant from the Rheumatology Research Foundation has set two physicians on a course to examine how high-density lipoprotein (HDL) cholesterol is different in rheumatoid arthritis patients

Much at Stake for Rheumatology in Lame Duck Session of Congress

Staff  |  December 1, 2012

Massive mandatory spending cuts—including a near 30% cut to Medicare physician reimbursement—are scheduled to go into effect in January

Welcome New ACR and ARHP Leaders

Staff  |  December 1, 2012

The American College of Rheumatology (ACR) welcomes the newest members of the ACR board of directors and the Association of Rheumatology Health Professionals (ARHP) executive committee

Meet the 2013 ACR President Audrey B. Uknis, MD

Staff  |  December 1, 2012

A rheumatologist and professor at Temple University School of Medicine in Philadelphia, Dr. Uknis was named 2013 president at the American College of Rheumatology (ACR) annual business meeting last month

Coding Corner Question: December

Staff  |  December 1, 2012

Test your coding knowledge for an office visit by a 60-year-old patient with severe rheumatoid arthritis who has an adverse reaction to an infliximab infusion, requiring her IV to be flushed with saline and pushed with diphenhydramine.

Coding Corner Answer: December Coding Challenge

Staff  |  December 1, 2012

Coding for an office visit by a patient with severe rheumatoid arthritis who experiences an adverse reaction to an infliximab infusion and has her IV flushed with saline and pushed with diphenhydramine.

Money Matters in Running a Rheumatology Practice

Staff  |  December 1, 2012

As the practice owner, you need to understand all of the in-house finance systems and functions

Facebook Chats Link Healthcare Providers with Patients

Carol Patton  |  December 1, 2012

Facebook chats organized by the Hospital for Special Surgery in New York City help rheumatologists convey information online to patients

The ACR Honors Contributions to Rheumatology

Richard Quinn  |  December 1, 2012

The American College of Rheumatology (ACR) recognizes a group of distinguished individuals for their contributions to rheumatology research, education, and patient care

ACR/ARHP Annual Meeting 2012: Spondylarthritis Criteria Changing Landscape of the Disease

Thomas R. Collins  |  December 1, 2012

More finely tuned view of ankylosing spondylitis leads to better treatment, expert says

How to Bring the Physician-Patient Relationship to a Peaceful End

Steven M. Harris, Esq.  |  December 1, 2012

Direct communication and a concern for the patient’s welfare should guide the process of terminating a physician-patient relationship

CORRONA Team Provides Data-Based Tool to Address Rheumatology’s Questions

Gretchen Henkel  |  December 1, 2012

The Consortium of Rheumatology Researchers of North America (CORRONA) patient registry collects a host of treatment and disease indicators for a variety of rheumatic diseases at every physician visit

Ethical Concerns Influence What Constitutes Clear and Full Disclosure for Physicians

Bernard Rubin, DO, MPH  |  December 1, 2012

Money received from industry by physicians who can influence medical practice by their research, opinions, or roles in decision-making bodies should be clearly and fully disclosed

Ethics in Patients’ End-of-Life Care Compound Therapeutic Challenges for Rheumatologists

C. Ronald MacKenzie, MD  |  December 1, 2012

While end-of-life decisions are not frequently encountered in day-to-day practice, rheumatologists should be familiar with the ethical challenges that may arise when caring for patients in the ICU

Issue Archive

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences